ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations

February 3, 1984

Institute of Medicine Elects 80 New Members

October 24, 2014

In Brief: Sparano Named Vice Chair of ECOG-ACRIN

May 17, 2013

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

In Brief: Univ. Of Pittsburgh Creates Genetics Institute; Elion Inducted Into Inventors Hall of Fame

April 5, 1991

Satcher Nominated For Surgeon General, Asst. Sec. for Health.

September 19, 1997